R-Bio
Pre-clinicalDiscover how rBIO’s synthetic biology platform is revolutionizing insulin production to lower costs and enhance U.S. pharmaceutical resilience.
Founded
2018
Focus
Biosimilars
About
Discover how rBIO’s synthetic biology platform is revolutionizing insulin production to lower costs and enhance U.S. pharmaceutical resilience.
Company Info
TypePrivate
Founded2018
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile